Axsome Therapeutics price target raised to $200 from $170 at H.C. Wainwright
December 30, 2019 at 09:38 AM EST
H.C. Wainwright analyst Raghuram Selvaraju raised his price target on Axsome Therapeutics shares to $200 from $170.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|